Head to head

Envision vs V30 (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $50k–$80k for V30. No new-price range is on file for Envision. Check the source notes and request current quotes.
Practice fit: Both are listed under IPL multi-app platform. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

IPL multi-app platform

View full device profile →

Device B

IPL multi-app platform

View full device profile →

Price comparison

Price comparison: InMode Envision vs Viora V30
Attribute	InMode Envision	Viora V30
New price range	Not published	$50k–$80kSource not documented
Used asking range	Not published	$20k–$35kSource not documented
Payback calculator	View cost details	View ROI calculator
Next step

New price range

InMode Envision: Not published
Viora V30: $50k–$80kSource not documented

Used asking range

InMode Envision: Not published
Viora V30: $20k–$35kSource not documented

Payback calculator

InMode Envision: View cost details
Viora V30: View ROI calculator

Next step

InMode Envision

Viora V30

Consumable economics

Consumable economics: InMode Envision vs Viora V30
Attribute	InMode Envision	Viora V30
Consumable cost / lock-in	—	—
Service cost	Not published	Not published

Consumable cost / lock-in

InMode Envision: —
Viora V30: —

Service cost

InMode Envision: Not published
Viora V30: Not published

FDA clearance

FDA clearance: InMode Envision vs Viora V30
Attribute	InMode Envision	Viora V30
FDA status & indication	FDA ClearedK221571, K210492, K200293 Read FDA indication wording “The InMode Multi System with the Diode laser Applicators is indicated for: • Diolaze XL 810nm Applicator is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. • Diolaze XL 755/810nm & 810/1064nm Applicators are intended for hair removal. • VLaze Applicator is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The InMode Multi System with the IPL Applicator is indicated for: • IPL Applicator with wavelengths (515-1200nm) is indicated for use for the following treatments: The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations. The InMode Multi System with the non-invasive RF Applicators is indicated for: • BodyFX (WMBody) and MiniFX Applicators are intended for the treatment of the following medical conditions: Relief of minor muscle aches and pains, relief of muscle spasm, temporary improvement of local blood circulation; and temporary reduction in the appearance of cellulite. • PLUS/ PLUS90/PLUS-PLUS (FORMA) and i-Forma Applicators are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation. • FaceFX (WMFace) Applicator is intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and rhytids. The InMode Multi System with the Fractional RF Applicators is indicated for: • FRACTORA 60 pin Applicator is intended for use in dermatological procedures requiring ablation and resurfacing of the skin. • FRF 24 pin Applicator is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. • Fractora3D and Morpheus8 Applicators are intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use is limited to Skin Types I-IV.”	FDA ClearedK133837 Read FDA indication wording “The Viora V-total 7"' isintended for dermatological procedures. The ST handpiece is indicated for the treatment of relief of minor muscle aches and pain, relief of muscle spasm and temporary improvement of local blood circulation. The IPL handpiece with wavelengths 415-l200nm (with 5 different filters) is indicated for the treatment of:. * Moderate inflammatory acne vulgaris. * Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasrna, and ephelides (freckles). * Cutaneous lesions including warts, scars and striae. "Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacca, erythema of rosacca, angiomnas and spider angiomnas, poikiloderma of Civatte and venous malformations. * Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction inthe number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Nd:YAG Laser handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm. The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for: - Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias). reticular veins (0. 1-4.0mmn dia.) of the leg, rosace, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas. * Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis. * Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of One, chloasma, verrucae, skin tags and keratosis. - Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. ' The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles. "The handpiece with a spot size of 9.5 mm is also intended for treatment of: Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral pant of the scar.”

FDA status & indication

InMode Envision: FDA ClearedK221571, K210492, K200293
Read FDA indication wording
“The InMode Multi System with the Diode laser Applicators is indicated for: • Diolaze XL 810nm Applicator is intended for hair removal and permanent hair reduction defined as the stable, long-term reduction in hair counts at 6, 9, or 12 months following a treatment regime. • Diolaze XL 755/810nm & 810/1064nm Applicators are intended for hair removal. • VLaze Applicator is intended for the treatment of vascular lesions, including angiomas, hemangiomas, telangiectasia, port wine stains, leg veins and other benign vascular lesions. The InMode Multi System with the IPL Applicator is indicated for: • IPL Applicator with wavelengths (515-1200nm) is indicated for use for the following treatments: The treatment of benign pigmented epidermal lesions, including dyschromia, hyperpigmentation, melasma, ephelides (freckles); The treatment of benign cutaneous vascular lesions, including port wine stains, facial, truncal and leg telangiectasias, rosacea, erythema of rosacea, angiomas and spider angiomas, poikilodenna of Civatte, superficial leg veins and venlous malformations. The InMode Multi System with the non-invasive RF Applicators is indicated for: • BodyFX (WMBody) and MiniFX Applicators are intended for the treatment of the following medical conditions: Relief of minor muscle aches and pains, relief of muscle spasm, temporary improvement of local blood circulation; and temporary reduction in the appearance of cellulite. • PLUS/ PLUS90/PLUS-PLUS (FORMA) and i-Forma Applicators are indicated for the temporary relief of minor muscle aches and pain, temporary relief of muscle spasm, and temporary improvement of local blood circulation. • FaceFX (WMFace) Applicator is intended for use in dermatologic procedures, for noninvasive treatment of mild to moderate facial wrinkles and rhytids. The InMode Multi System with the Fractional RF Applicators is indicated for: • FRACTORA 60 pin Applicator is intended for use in dermatological procedures requiring ablation and resurfacing of the skin. • FRF 24 pin Applicator is intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. • Fractora3D and Morpheus8 Applicators are intended for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. At higher energy levels greater than 62 mJ/pin, use is limited to Skin Types I-IV.”
Viora V30: FDA ClearedK133837
Read FDA indication wording
“The Viora V-total 7"' isintended for dermatological procedures. The ST handpiece is indicated for the treatment of relief of minor muscle aches and pain, relief of muscle spasm and temporary improvement of local blood circulation. The IPL handpiece with wavelengths 415-l200nm (with 5 different filters) is indicated for the treatment of:. * Moderate inflammatory acne vulgaris. * Benign pigmented epidermal lesions including dyschromia, hyperpigmentation, melasrna, and ephelides (freckles). * Cutaneous lesions including warts, scars and striae. "Benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacca, erythema of rosacca, angiomnas and spider angiomnas, poikiloderma of Civatte and venous malformations. * Removal unwanted hair. It is also intended for permanent reduction in unwanted hair. Permanent hair reduction is defined as the long-term stable reduction inthe number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Nd:YAG Laser handpiece with wavelength 1064 nm comes with 4 different applicator spot diameters: 2x4, 3.5, 5.5 and 9.5 mm. The three smaller spot sizes (2x4, 3.5, 5.5 mm) are intended for: - Benign vascular lesions such as, but not limited to treatment of: port wine stains, hemangiomas, Warts, superficial and deep telangiectasias (venulectasias). reticular veins (0. 1-4.0mmn dia.) of the leg, rosace, venus lake, leg veins, spider veins, poikiloderma of civatte and angiomas. * Benign cutaneous lesions, such as, but not limited to: warts, scars, striae and psoriasis. * Benign pigmented lesions such as, but not limited to: lentigos (age spots), solar lentigos (sun spots), cafe-aulait macules, seborrheic keratosis, nevi and nevus of One, chloasma, verrucae, skin tags and keratosis. - Pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. ' The non-ablative treatment of facial wrinkles, such as, but not limited to: periocular wrinkles and perioral wrinkles. "The handpiece with a spot size of 9.5 mm is also intended for treatment of: Laser skin resurfacing procedures for the treatment of: acne scars and wrinkles. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral pant of the scar.”

Which chains run each

Which chains run each: InMode Envision vs Viora V30
Attribute	InMode Envision	Viora V30
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

InMode Envision: 0 recorded pairings
Viora V30: 0 recorded pairings

Chains using it

InMode Envision: —
Viora V30: —

Approved reviews

InMode Envision: 0
Viora V30: 0

Specs and platform

Specs and platform: InMode Envision vs Viora V30
Attribute	InMode Envision	Viora V30
Manufacturer	InMode	Viora
Built by (OEM)	—	Viora Ltd.
Category	IPL multi-app platform	IPL multi-app platform
Technology	—	V-IPL + diode + RF modular (Diode laser)
Launch year	—	2018
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

InMode Envision: InMode
Viora V30: Viora

Built by (OEM)

InMode Envision: —
Viora V30: Viora Ltd.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Venus Versa Pro

IPL multi-app platform

New: $100k–$130k

Lumenis Stellar M22

IPL multi-app platform

New: $90k–$130k

InMode Optimas

IPL multi-app platform

New: $90k–$130k

SharpLight OmniMax S4

IPL multi-app platform

New: $60k–$90k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.